Spyre Therapeutics prices $350M stock offering at $85 per share Oct 5, 2026 08:14PM
Spyre Therapeutics Announces Pricing of $350.0 Million Public Offering of Common Stock Oct 5, 2026 08:13PM
Spyre Therapeutics launches public stock offering on Nasdaq Oct 5, 2026 04:01PM
Spyre Therapeutics Announces Proposed Public Offering of its Common Stock Oct 5, 2026 04:01PM
TD Cowen on Spyre (SYRE): 'we expect these data to further raise the ceiling for Spyre's future combos' Apr 13, 2026 07:57AM


Feb 24, 2026 04:05PM Spyre Therapeutics to Participate in Upcoming March Investor Conferences
Feb 25, 2025 08:00AM Spyre Therapeutics to Participate in Upcoming March Investor Conferences
Oct 14, 2024 02:18PM TD Cowen Reiterates Buy Rating on Spyre (SYRE)
Mar 18, 2024 08:07AM Spyre Therapeutics (SYRE) announced $180M private placement
Mar 18, 2024 08:00AM Spyre Therapeutics Announces $180 Million Private Placement
Feb 26, 2024 07:30AM Spyre Therapeutics to Participate in the 44th Annual TD Cowen Health Care Conference
Dec 7, 2023 06:20PM Spyre Therapeutics Announces $180 Million Private Placement